000 | 01065 a2200289 4500 | ||
---|---|---|---|
005 | 20250514003512.0 | ||
264 | 0 | _c20010920 | |
008 | 200109s 0 0 eng d | ||
022 | _a0095-1137 | ||
024 | 7 |
_a10.1128/JCM.39.7.2745-2746.2001 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBrown-Elliott, B A | |
245 | 0 | 0 |
_aClarithromycin resistance to Mycobacterium abscessus. _h[electronic resource] |
260 |
_bJournal of clinical microbiology _cJul 2001 |
||
300 |
_a2745-6 p. _bdigital |
||
500 | _aPublication Type: Comment; Letter | ||
650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
650 | 0 | 4 |
_aClarithromycin _xpharmacology |
650 | 0 | 4 |
_aCystic Fibrosis _xcomplications |
650 | 0 | 4 | _aDrug Resistance, Microbial |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMycobacterium _xclassification |
650 | 0 | 4 |
_aMycobacterium Infections _xmicrobiology |
700 | 1 | _aWallace, R J | |
773 | 0 |
_tJournal of clinical microbiology _gvol. 39 _gno. 7 _gp. 2745-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1128/JCM.39.7.2745-2746.2001 _zAvailable from publisher's website |
999 |
_c11375021 _d11375021 |